{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:38:33Z","timestamp":1787315913955,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40257-024-00905-9","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T13:49:08Z","timestamp":1733147348000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions"],"prefix":"10.1007","volume":"26","author":[{"given":"Olivia M.","family":"Katamanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella J.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6358-9068","authenticated-orcid":false,"given":"Mohammad","family":"Jafferany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"issue":"3","key":"905_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s40263-024-01068-1","volume":"38","author":"RE Christensen","year":"2024","unstructured":"Christensen RE, Jafferany M. Unmet needs in psychodermatology: a narrative review. CNS Drugs. 2024;38(3):193\u2013204.","journal-title":"CNS Drugs"},{"key":"905_CR2","doi-asserted-by":"publisher","unstructured":"Psychoneuroimmunology - Tausk - 2008 - Dermatologic Therapy - Wiley Online Library. [cited 2024 May 29]. Available from: https:\/\/doi.org\/10.1111\/j.1529-8019.2008.00166.x","DOI":"10.1111\/j.1529-8019.2008.00166.x"},{"issue":"277","key":"905_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jad.2020.08.001","volume":"1","author":"J Xiong","year":"2020","unstructured":"Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;1(277):55\u201364.","journal-title":"J Affect Disord"},{"issue":"154","key":"905_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2022.104104","volume":"1","author":"JE Bower","year":"2022","unstructured":"Bower JE, Radin A, Kuhlman KR. Psychoneuroimmunology in the time of COVID-19: Why neuro-immune interactions matter for mental and physical health. Behav Res Ther. 2022;1(154): 104104.","journal-title":"Behav Res Ther"},{"issue":"3","key":"905_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/j.2051-5545.2010.tb00298.x","volume":"9","author":"G Hasler","year":"2010","unstructured":"Hasler G. Pathophysiology of depression: Do we have any solid evidence of interest to clinicians? World Psychiatry. 2010;9(3):155\u201361.","journal-title":"World Psychiatry"},{"issue":"1","key":"905_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.31887\/DCNS.2002.4.1\/bbondy","volume":"4","author":"B Brigitta","year":"2002","unstructured":"Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2002;4(1):7\u201320.","journal-title":"Dialogues Clin Neurosci"},{"issue":"12","key":"905_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41398-017-0016-3","volume":"7","author":"R Gaspersz","year":"2017","unstructured":"Gaspersz R, Lamers F, Wittenberg G, Beekman ATF, van Hemert AM, Schoevers RA, et al. The role of anxious distress in immune dysregulation in patients with major depressive disorder. Transl Psychiatry. 2017;7(12):1268.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"905_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000490002","volume":"31","author":"D Farzanfar","year":"2018","unstructured":"Farzanfar D, Dowlati Y, French LE, Lowes MA, Alavi A. Inflammation: a contributor to depressive comorbidity in inflammatory skin disease. Skin Pharmacol Physiol. 2018;31(5):246\u201351.","journal-title":"Skin Pharmacol Physiol."},{"issue":"5","key":"905_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.92","volume":"6","author":"N Vogelzangs","year":"2016","unstructured":"Vogelzangs N, de Jonge P, Smit JH, Bahn S, Penninx BW. Cytokine production capacity in depression and anxiety. Transl Psychiatry. 2016;6(5): e825.","journal-title":"Transl Psychiatry"},{"issue":"9","key":"905_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.137","volume":"5","author":"J Verduijn","year":"2015","unstructured":"Verduijn J, Milaneschi Y, Schoevers RA, van Hemert AM, Beekman ATF, Penninx BWJH. Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression. Transl Psychiatry. 2015;5(9): e649.","journal-title":"Transl Psychiatry"},{"key":"905_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106145","volume":"179","author":"B Li","year":"2022","unstructured":"Li B, Yang W, Ge T, Wang Y, Cui R. Stress induced microglial activation contributes to depression. Pharmacol Res. 2022;179: 106145.","journal-title":"Pharmacol Res"},{"issue":"6","key":"905_CR12","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.euroneuro.2017.04.001","volume":"27","author":"CM Pariante","year":"2017","unstructured":"Pariante CM. Why are depressed patients inflamed? A reflection on 20 years of research on depression, glucocorticoid resistance and inflammation. Eur Neuropsychopharmacol. 2017;27(6):554\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"905_CR13","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/jdv.14460","volume":"31","author":"J Koo","year":"2017","unstructured":"Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017;31(12):1999\u20132009.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"905_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaad.2021.06.843","volume":"86","author":"S Wright","year":"2022","unstructured":"Wright S, Strunk A, Garg A. Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa. J Am Acad Dermatol. 2022;86(1):55\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"905_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","volume":"139","author":"ZC Chiesa Fuxench","year":"2019","unstructured":"Chiesa Fuxench ZC, Block JK, Boguniewicz M, Boyle J, Fonacier L, Gelfand JM, et al. Atopic Dermatitis in America Study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US Adult Population. J Invest Dermatol. 2019;139(3):583\u201390.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"905_CR16","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1402a104","volume":"14","author":"E Mitsiou","year":"2024","unstructured":"Mitsiou E, Kyriakou A, Parlapani E, Trigoni A, Trakatelli M, Apalla Z, et al. Correlation of specific inflammatory markers with the occurrence of depression in patients with psoriasis and their use as biomarkers for the diagnosis of depression. Dermatol Pract Concept. 2024;14(2): e2024104.","journal-title":"Dermatol Pract Concept."},{"issue":"8","key":"905_CR17","first-page":"891","volume":"146","author":"SK Kurd","year":"2010","unstructured":"Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891\u20135.","journal-title":"Arch Dermatol"},{"issue":"1","key":"905_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jaip.2019.08.030","volume":"8","author":"Y Schonmann","year":"2020","unstructured":"Schonmann Y, Mansfield KE, Hayes JF, Abuabara K, Roberts A, Smeeth L, et al. Atopic eczema in adulthood and risk of depression and anxiety: a population-based cohort study. J Allergy Clin Immunol Pract. 2020;8(1):248-257.e16.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"905_CR19","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2249","volume":"64","author":"M Fabrazzo","year":"2021","unstructured":"Fabrazzo M, Cipolla S, Signoriello S, Camerlengo A, Calabrese G, Giordano GM, et al. A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. Eur Psychiatry J Assoc Eur Psychiatr. 2021;64(1): e71.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr."},{"key":"905_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2017.05.018","volume":"97","author":"A Nadeem","year":"2017","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Fardan AS, El-Sherbeeny AM, Ibrahim KE, et al. IL-17A causes depression-like symptoms via NF\u03baB and p38MAPK signaling pathways in mice: implications for psoriasis associated depression. Cytokine. 2017;97:14\u201324.","journal-title":"Cytokine"},{"issue":"9","key":"905_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1111\/jdv.19192","volume":"37","author":"U Mrowietz","year":"2023","unstructured":"Mrowietz U, S\u00fcmb\u00fcl M, Gerdes S. Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation. J Eur Acad Dermatol Venereol. 2023;37(9):1731\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"905_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0923-1811(97)00074-1","volume":"16","author":"M Hashiro","year":"1998","unstructured":"Hashiro M, Okumura M. The relationship between the psychological and immunological state in patients with atopic dermatitis. J Dermatol Sci. 1998;16(3):231\u20135.","journal-title":"J Dermatol Sci"},{"issue":"8","key":"905_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201589","volume":"13","author":"D Pietrzak","year":"2018","unstructured":"Pietrzak D, Pietrzak A, Grywalska E, Kici\u0144ski P, Roli\u0144ski J, Donica H, et al. Serum concentrations of interleukin 18 and 25-hydroxyvitamin D3 correlate with depression severity in men with psoriasis. PLoS\u00a0One. 2018;13(8): e0201589.","journal-title":"PLoS\u00a0One"},{"key":"905_CR24","unstructured":"AJMC. Addressing the psychosocial impacts of inflammatory skin conditions in patient care. 2023. Available from: https:\/\/www.ajmc.com\/view\/addressing-the-psychosocial-impacts-of-inflammatory-skin-conditions-in-patient-care"},{"issue":"10","key":"905_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/CCID.S111041","volume":"20","author":"CJ Connor","year":"2017","unstructured":"Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners\u2019 guidelines. Clin Cosmet Investig Dermatol. 2017;20(10):117\u201332.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"905_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","volume":"107","author":"MM Chren","year":"1996","unstructured":"Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707\u201313.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"905_CR27","first-page":"202","volume":"136","author":"M Morgan","year":"1997","unstructured":"Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales\u2014a measure of the impact of skin diseases. Br J Dermatol. 1997;136(2):202\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"905_CR28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"905_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/bjd.14788","volume":"176","author":"FM Ali","year":"2017","unstructured":"Ali FM, Cueva AC, Vyas J, Atwan AA, Salek MS, Finlay AY, et al. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. Br J Dermatol. 2017;176(3):577\u201393.","journal-title":"Br J Dermatol"},{"issue":"5","key":"905_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40257-017-0279-8","volume":"18","author":"N Patel","year":"2017","unstructured":"Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, et al. Psoriasis, depression, and inflammatory overlap: a review. Am J Clin Dermatol. 2017;18(5):613\u201320.","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"905_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat. 2013;70(1):31\u201341.","journal-title":"JAMA Psychiat"},{"issue":"9504","key":"905_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet Lond Engl. 2006;367(9504):29\u201335.","journal-title":"Lancet Lond Engl."},{"issue":"27","key":"905_CR33","volume":"30","author":"JC Zwiep","year":"2022","unstructured":"Zwiep JC, Bet PM, Rhebergen D, Nurmohamed MT, Vinkers CH, Penninx BWJH, et al. Efficacy of celecoxib add-on treatment for immuno-metabolic depression: protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial. Brain Behav Immun - Health. 2022;30(27): 100585.","journal-title":"Brain Behav Immun - Health."},{"key":"905_CR34","doi-asserted-by":"crossref","unstructured":"Agnese ER, Tariche N, Sharma A, Gulati R, Agnese ER, Tariche N, et al. The pathogenesis and treatment of hidradenitis suppurativa. Cureus. 2023;15(11). Available from: https:\/\/www.cureus.com\/articles\/204594-the-pathogenesis-and-treatment-of-hidradenitis-suppurativa","DOI":"10.7759\/cureus.49390"},{"issue":"1","key":"905_CR35","doi-asserted-by":"publisher","first-page":"8844","DOI":"10.1038\/s41598-024-59162-9","volume":"14","author":"SP Hartono","year":"2024","unstructured":"Hartono SP, Chatrath S, Aktas ON, Kubala SA, Capozza K, Myles IA, et al. Interventions for anxiety and depression in patients with atopic dermatitis: a systematic review and meta-analysis. Sci Rep. 2024;14(1):8844.","journal-title":"Sci Rep"},{"issue":"3","key":"905_CR36","first-page":"401","volume":"21","author":"P Filakovi\u0107","year":"2009","unstructured":"Filakovi\u0107 P, Petek A, Koi\u0107 O, Radanovi\u0107-Grguri\u0107 L, Degmeci\u0107 D. Comorbidity of depressive and dermatologic disorders\u2014therapeutic aspects. Psychiatr Danub. 2009;21(3):401\u201310.","journal-title":"Psychiatr Danub"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-024-00905-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00905-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T02:49:04Z","timestamp":1737082144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-024-00905-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s40257-024-00905-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"29 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive funding from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors confirm that the data supporting the findings of this study are available within the article and\/or its supplementary materials.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability (Software Application or Custom Code)"}},{"value":"All authors listed contributed to the design of the research, to the analysis of the results, and to the writing of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}